Viewing Study NCT06056050



Ignite Creation Date: 2024-05-06 @ 7:34 PM
Last Modification Date: 2024-10-26 @ 3:09 PM
Study NCT ID: NCT06056050
Status: RECRUITING
Last Update Posted: 2023-12-20
First Post: 2023-09-19

Brief Title: A Clinical Trial of Adsorbed Cell-free DPT Vaccine 5-component for People Aged 6 Years and Above
Sponsor: CanSino Biologics Inc
Organization: CanSino Biologics Inc

Study Overview

Official Title: A Randomized Blinded Controlled Phase I Clinical Trial for Preliminary Evaluation of the Safety and Immunogenicity of Adsorbed Cell-free DPT Vaccine for People Aged 6 Years and Above
Status: RECRUITING
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Pertussis is an acute respiratory infectious disease caused by Bordetella pertussis diphtheria is an acute upper respiratory infectious disease caused by Gram-positive Corynebacterium diphtheriae and tetanus is a highly fatal disease caused by Clostridium tetani infection Currently there is no clinical trial registration of Diphtheria tetanus and pertussis DPT vaccine applicable to 6 years of age in China therefore the five-component acellular DPT combination vaccine developed by our research has a promising future
Detailed Description: The vaccines used in Chinas immunization program for the prevention of pertussis tetanus and diphtheria include the adsorbed cell-free diphtheria-tetanus-acellular pertussis vaccine DTaP and the diphtheria-tetanus-acellular tetanus vaccine DT and tetanus vaccine Among them DTaP vaccination is for children from 3 months of age to 6 years of age with one dose each at 3 4 5 and 18 months of age DT vaccination is for children under 12 years of age with one dose at 6 weeks of age after completing four doses of DTaP vaccination However infant and young child vaccination is no longer sufficient to prevent the threat of this disease mainly due to the rapid decay of immune protection in adolescents and adults and infections in this population which are the main source of infection leading to infection in infants and young children have been a number of new preventive strategies are being evaluated

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None